Intravenous Plaquex Therapy

Phospholipids, particularly phosphatidyl choline (PC), are essential to life and tissue function. They are the major building block of cell membranes which surround every cell in the body and allow for healthy cellular function and communication.

Intravenous PC is called Plaquex therapy. It has several actions including decreasing plaquing in arteries, improving circulation (especially in Diabetics), boosting sexual performance, reversing the ravages of aging, acting as a potent liver detoxifier, and detoxifying biotoxins and toxic heavy metals.

lthough our bodies produce PC, with age this synthesis is impeded. Other phospholipids and cholesterol increase. The effect of this is an inability of cells to let nourishment in and toxins out, an inability of chemical receptors to function properly in the cell membrane, an increase in arterial plaquing and atherosclerosis, and a decrease in the ability of the heart to pump blood through ever narrowing arteries.

Research has shown that intravenous PC has a regenerative and revitalizing effect on the entire body. In animal studies this treatment has extended life by 36%. It lowers cholesterol, improves membrane permeability and function, decreases blood clotting, and improves cellular energy production. In human studies, Plaquex therapy has proven itself to be a first-rate treatment in diseases involving arterial plaquing (the number one killer in North America). It lowers the severity of angina, and increases exercise tolerance as well as diminishing symptoms of Intermittent Claudication (pain in the legs with exertion). Objective testing has shown that after a series of Plaquex therapy IV’s, severe heart disease patients had no perfusion problems. Their skin colour and temperature as well as pulses normalized. Further, those with leg pain from walking became pain-free with walking and those with angina experienced less chest pain or even no chest pain at all. On average after a series of these treatments HDL (good cholesterol) increased by 25%, total cholesterol decreased by 8.8-28%, and triglyceride fats in the blood decreased by 25%.

Other research has shown this treatment to improve a person’s energy, make them feel and look younger, increase libido, and improve overall health. Further, it protects the liver from toxins and greatly enhances the ability of the liver to detoxify chemicals. Studies have proven Plaque therapy to reverse fatty liver and liver damage. A study published in the prestigious journal JAMA showed that just 5 Plaquex treatments decreased arterial plaquing by 4.2% which translated to a 20% increase in blood flow.

Generally, 10-30 Plaquex therapy treatments at 1-3 weekly may be required depending on individual needs. This therapy combines well with intravenous Glutathione and often the two are administered together in a treatment called “Phospholipid Exchange”. Also, Plaquex Therapy is often alternated with Chelation Therapy for a more complete therapeutic effect.